How to use new biology to guide therapy in multiple myeloma.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 342-349

  Morgan, Gareth J ^a   Kaiser, Martin F ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CHROMOSOME ABERRATION; DISEASE COURSE; GENE TRANSLOCATION; GENETIC EPIGENESIS; GENETIC MARKER; GENETIC VARIABILITY; GENETICS; GENOME; HUMAN; METHODOLOGY; MULTIPLE MYELOMA; ONCOLOGY; PLASMA CELL LEUKEMIA; PROGNOSIS; REVIEW; RISK; TREATMENT OUTCOME;

CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; EPIGENESIS, GENETIC; GENETIC MARKERS; GENETIC VARIATION; GENOME; HUMANS; LEUKEMIA, PLASMA CELL; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; PROGNOSIS; RISK; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877115165     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.342.3798324     Document Type: Review

References (0)